Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
US7790863B2 · kind B2 · utility
5Cited by
13References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2004 |
| Grant date | Sep 7, 2010 |
| Priority date | — |
| Expiry date | Feb 23, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to angiogenesis inhibiting molecules that are the monoclonal antibody H33 or fragments or derivatives thereof, to their use in the treatment of cancer, in particular the treatment of solid tumors and to therapeutic and diagnostic compositions comprising them. The invention relates in particular to humanized derivatives of H33 of human monoclonal antibodies having the specificity of H33.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.